Align Financial’s Gilead Sciences GILD Stock Holding History

Align Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.68K	Buy	+18	New	+$2.53K	﹤0.01%	337

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Align Financial's GILD Position: Q3 2026 in Review

Align Financial opened a new position in Gilead Sciences (GILD) in Q3 2026: 18 shares worth $2.68K. The stake represents ﹤0.01% of the portfolio and ranks #337 among its holdings.

816 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Align Financial held 18 shares of Gilead Sciences worth $2.68K as of Q3 2026.
Gilead Sciences was a new Align Financial position in Q3 2026.
Gilead Sciences made up ﹤0.01% of Align Financial's portfolio in Q3 2026, its #337 holding.
816 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Align Financial's 13F filing for Q3 2026, filed 16 Oct 2026.